 |
|
|
||||||||||||||
 |
|
|
Click the links below to read a full description of each position.
Send your resume to jobs@tethysbio.comRegional Account Manager - Valdosta, GA (HR258)
Regional Account Manager - Savannah, GA (HR243)
Regional Account Manager - Knoxville, TN (HR241)
Regional Account Manager - Montgomery, AL (HR240)
Regional Account Manager - Fort Smith, AR (HR260)
Regional Account Manager - Little Rock, AR (HR259)
Regional Account Manager - Dallas, TX (HR239)
Regional Account Manager - Omaha, NE (HR247)
Regional Account Manager - Springfield IL (HR246)
Regional Account Manager - Rochester, MN (HR245)
Regional Account Manager - Cincinnati, OH (HR237)
Regional Account Manager - Winston-Salem, NC (HR257)
Regional Account Manager - Myrtle Beach, SC (HR254)
Regional Account Manager - Greenville, SC (HR235)
Regional Account Manager - Roanoke, VA (HR256)
Regional Account Manager - Norfolk, VA (HR255)
Regional Account Manager - Charlottesville, VA (HR236)
Regional Account Manager - Harrisburg, PA (HR253)
Regional Account Manager - Wilmington, DE (HR252)
Regional Account Manager - Hartford, CT (HR251)
Regional Account Manager - Philadelphia, PA (HR250)
Regional Account Manager - Newark, NJ (HR249)
Regional Account Manager - Lubbock, Texas (HR261)
Regional Account Manager - Baltimore, MD (HR248)
Manager of Billing Operations (HR204)
Senior Operations Engineer (HR217)
Manager, Sales Analytics (HR 191)
Mass Spectrometry Specialist (HR131)
Jul 22, 2010
Tethys Raises $33 Million
Tethys Bioscience, Inc., announced today that the company has recently raised $33 million, comprising $23 million of venture financing and a $10 million working capital loan.
Jul 14, 2010
Diabetes Risk, on a Scale of 1 to 10
A new test is transforming the way some doctors diagnose and treat their patients.
(Technology Review)
Jul 1, 2010
PreDx® featured on CBS Interactive's Smartplanet
CBS Interactive smartplanet video segment focuses on the impact of the PreDx® Diabetes Risk Score on the physician and patient.
Jun 24, 2010
Tethys Announces Issuance of Key Patent Relating to PreDx™ Diabetes Risk Score Test
United States Patent and Trademark Office grants patent to Tethys. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.
Nov 9, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
The financing round is led by aeris Capital with George Rehm taking a seat on the Tethys board.
Oct 20, 2009
Gazing into the Future
(Journal of Life Sciences, Fall 2009)